Developing a dissociative nanocontainer for peptide drug delivery

International Journal of Environmental Research and Public Health

Volumn 12, Issue 10, 2015, Pages 12543-12555

  Kelly, Patrick ^a   Anand, Prachi ^a   Uvaydov, Alexander ^a   Chakravartula, Srinivas ^a   Sherpa, Chhime ^a   Pires, Elena ^a   O’Neil, Alison ^b   Douglas, Trevor ^c   Holford, Mandë ^a,d  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b Harvard University   (United States)

^c INDIANA UNIVERSITY   (United States)

^d DIVISION OF INVERTEBRATE ZOOLOGY   (United States)

Author keywords

Controlled disassembly; Drug delivery; Grubbs catalyst; Nanocontainers; P22 bacteriophage; Peptide therapeutics; ROMP; Triggered release; Venom peptides; Viral capsid

Indexed keywords

5 NORBORNENE 2 CARBOXYLIC ACID; ANALGESIC AGENT; CARBOXYLIC ACID; NANOCARRIER; UNCLASSIFIED DRUG; CAPSID PROTEIN; NANOCAPSULE; PEPTIDE;

BACTERIOPHAGE; CATALYST; DRUG; MEDICINE; NANOTECHNOLOGY; PEPTIDE;

ARTICLE; BLOOD BRAIN BARRIER; CHEMICAL REACTION; CONFOCAL FLUORESCENCE MICROSCOPY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENTEROBACTERIA PHAGE P22; IN VIVO STUDY; LIGHT SCATTERING; NANOENCAPSULATION; RING OPENING METATHESIS POLYMERIZATION REACTION; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CAPSID; CHEMISTRY; HUMAN; PROCEDURES;

MIRIDAE;

BACTERIOPHAGE P22; CAPSID PROTEINS; DRUG DELIVERY SYSTEMS; HUMANS; NANOCAPSULES; PEPTIDES;

EID: 84944096951     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph121012543     Document Type: Article

References (38)

1. Marx, V. Watching peptide drugs grow up. Chem. Eng. News 2005, 83, 17–24.
2. Craik, D.J.; Fairlie, D.P.; Liras, S.; Price, D. The future of peptide-based drugs. Chem. Biol. Drug Des. 2013, 81, 136–147.
3. Kaspar, A.A.; Reichert, J.M. Future directions for peptide therapeutics development. Drug Discov. Today 2013, 18, 807–817.
4. King, G.F. Venoms as a platform for human drugs: Translating toxins into therapeutics. Expert Opin. Biol. Ther. 2011, 11, 1469–1484.
5. Koh, C.Y.; Kini, R.M. From snake venom toxins to therapeutics—Cardiovascular examples. Toxicon 2012, 59, 497–506.
6. Puillandre, N.; Holford, M. The terebridae and teretoxins: Combining phylogeny and anatomy for concerted discovery of bioactive compounds. BMC Chem. Biol. 2010, 10, doi:10.1186/1472-6769-10-7.
7. Von Reumont, B.; Campbell, L.; Jenner, R. Quo vadis venomics? A roadmap to neglected venomous invertebrates. Toxins 2014, 6, 3488–3551.
8. Oliveira, A.G. ω-Conotoxin MVIIA: From marine snail venom to analgesic drug. In Drugs from the Sea; Fusetani, N., Ed.; Karger: Basel, Switzerland, 2000; pp. 75–85.
9. Olivera, B.M.; Cruz, L.J.; de Santos, V.; LeCheminant, G.W.; Griffin, D.; Zeikus, R.; McIntosh, J.M.; Galyean, R.; Varga, J.; Gray, W.R. Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from conus magus venom. Biochemistry 1987, 26, 2086–2090.
10. Miljanich, G.P. Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain. Curr. Med. Chem. 2004, 11, 3029–3040.
11. Tsomaia, N. Peptide therapeutics: Targeting the undruggable space. Eur. J. Med. Chem. 2015, 94, 459–470.
12. Anand, P.; O’Neil, A.; Lin, E.; Douglas, T.; Holford, M. Tailored delivery of analgesic ziconotide across a blood brain barrier model using viral nanocontainers. Sci. Rep. 2015, 5, doi:10.1038/srep12497.
13. Fleige, E.; Quadir, M.A.; Haag, R. Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications. Adv. Drug Deliv. Rev. 2012, 64, 866–884.
14. Lin, J.; Zhu, J.; Chen, T.; Lin, S.; Cai, C.; Zhang, L.; Zhuang, Y.; Wang, X.S. Drug releasing behavior of hybrid micelles containing polypeptide triblock copolymer. Biomaterials 2009, 30, 108–117.
15. Lian, T.; Ho, R.J. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 2001, 90, 667–680.
16. Douglas, S.M.; Bachelet, I.; Church, G.M. A logic-gated nanorobot for targeted transport of molecular payloads. Science 2012, 335, 831–834.
17. Ma, Y.; Nolte, R.J.M.; Cornelissen, J.J.L.M. Virus-based nanocarriers for drug delivery. Adv. Drug Deliv. Rev. 2012, 64, 811–825.
18. Schoonen, L.; van Hest, J.C.M. Functionalization of protein-based nanocages for drug delivery applications. Nanoscale 2014, 6, 7124–7141.
19. Ren, Y.; Sek, M.W.; Lim, L.Y. Folic acid-conjugated protein cages of a plant virus: A novel delivery platform for doxorubicin. Bioconjug. Chem. 2007, 18, 836–843.
20. Tong, G.J.; Hsiao, S.C.; Carrico, Z.M.; Francis, M.B. Viral capsid DNA aptamer conjugates as multivalent cell targeting vehicles. J. Am. Chem.Soc. 2010, 131, 11174–11178.
21. Kang, S.; Uchida, M.; Oneil, A.; Li, R.; Prevelige, P.E.; Douglas, T. Implementation of P22 viral capsids as nanoplatforms. Biomacromolecules 2010, 11, 2804–2809.
22. Parker, M.H.; Casjens, S.; Prevelige, P.E. Functional domains of bacteriophage P22 scaffolding protein. J. Mol. Biol. 1998, 281, 69–79.
23. O’Neil, A.; Reichhardt, C.; Johnson, B.; Prevelige, P.E.; Douglas, T. Genetically programmed in vivo packaging of protein cargo and its controlled release from bacteriophage P22. Angew. Chem. Int. Ed. Engl. 2011, 50, 7425–7428.
24. Patterson, D.P.; Prevelige, P.E.; Douglas, T. Nanoreactors by programmed enzyme encapsulation inside the capsid of the bacteriophage P22. ACS Nano 2012, 6, 5000–5009.
25. Binder, J.B.; Raines, R.T. Olefin metathesis for chemical biology. Curr. Opin. Chem. Biol. 2008, 12, 767–773.
26. Brendgen, T.; Fahlbusch, T.; Frank, M.; Schühle, D.T.; Seßler, M.; Schatz, J. Metathesis in pure water mediated by supramolecular additives. Adv. Synth. Catal. 2009, 351, 303–307.
27. Mura, S.; Nicolas, J.; Couvreur, P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 2013, 12, 991–1003.
28. Teschke, C.M.; McGough, A.; Thuman-Commike, P.A. Penton release from P22 heat-expanded capsids suggests importance of stabilizing penton-hexon interactions during capsid maturation. Biophys. J. 2003, 84, 2585–2592.
29. Kaiser, C.R.; Flenniken, M.L.; Gillitzer, E.; Harmsen, A.L.; Harmsen, A.G.; Jutila, M.A.; Douglas, T.; Young, M.J. Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo. Int. J. Nanomedicine 2007, 2, 715–733.
30. Patel, P.R.; Kiser, R.C.; Lu, Y.Y.; Fong, E.; Ho, W.C.; Tirrell, D.A.; Grubbs, R.H. Synthesis and cell adhesive properties of linear and cyclic RGD functionalized polynorbornene thin films. Biomacromolecules 2012, 13, 2546–2553.
31. Trnka, T.M.; Grubbs, R.H. The Development of L2X2Ru=CHR Olefin metathesis catalysts: An organometallic success story. Acc. Chem. Res. 2001, 34, 18–29.
32. Brabec, V.; Nováková, O. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Drug Resist. Updat. 2006, 9, 111–122.
33. Allardyce, C.S.; Dyson, P.J. Ruthenium in medicine: Current clinical uses and future prospects. Platin. Met. Rev. 2001, 45, 62–69.
34. Lipshutz, B.H.; Aguinaldo, G.T.; Ghorai, S.; Voigtritter, K. Olefin cross-metathesis reactions at room temperature using the nonionic amphiphile “PTS”: Just add water. Org. Lett. 2008, 10, 1325–1328.
35. Schrock, R.R. Recent advances in olefin metathesis by molybdenum and tungsten imido alkylidene complexes. J. Mol. Catal. A Chem. 2004, 213, 21–30.
36. Schrock, R.R.; Hoveyda, A.H. Molybdenum and tungsten imido alkylidene complexes as efficient olefin-metathesis catalysts. Angew. Chem. Int. Ed. Engl. 2003, 42, 4592–4633.
37. Ben-Asuly, A.; Aharoni, A.; Diesendruck, C.E.; Vidavsky, Y.; Goldberg, I.; Straub, B.F.; Lemcoff, N.G. Photoactivation of ruthenium olefin metathesis initiators. Organometallics 2009, 28, 4652–4655.
38. Fortin, D.L.; Banghart, M.R.; Dunn, T.W.; Borges, K.; Wagenaar, D.A.; Gaudry, Q.; Karakossian, M.H.; Otis, T.S.; Kristan, W.B.; Trauner, D.; Kramer, R.H. Photochemical control of endogenous ion channels and cellular excitability. Nat. Methods 2008, 5, 331–338.